rs144914894

Variant summary

Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_181303.2(NLGN3):​c.1954A>G​(p.Thr652Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00383 in 1,210,181 control chromosomes in the GnomAD database, including 10 homozygotes. There are 1,432 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0020 ( 0 hom., 56 hem., cov: 22)
Exomes 𝑓: 0.0040 ( 10 hom. 1376 hem. )

Consequence

NLGN3
NM_181303.2 missense

Scores

1
16

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 2.24
Variant links:
Genes affected
NLGN3 (HGNC:14289): (neuroligin 3) This gene encodes a member of a family of neuronal cell surface proteins. Members of this family may act as splice site-specific ligands for beta-neurexins and may be involved in the formation and remodeling of central nervous system synapses. Mutations in this gene may be associated with autism and Asperger syndrome. Multiple transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Oct 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.005596161).
BP6
Variant X-71169504-A-G is Benign according to our data. Variant chrX-71169504-A-G is described in ClinVar as [Likely_benign]. Clinvar id is 167363.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-71169504-A-G is described in Lovd as [Likely_benign]. Variant chrX-71169504-A-G is described in Lovd as [Benign].
BS2
High Hemizygotes in GnomAd4 at 56 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NLGN3NM_181303.2 linkc.1954A>G p.Thr652Ala missense_variant Exon 8 of 8 ENST00000358741.4 NP_851820.1 Q9NZ94-1X5DNV3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NLGN3ENST00000358741.4 linkc.1954A>G p.Thr652Ala missense_variant Exon 8 of 8 5 NM_181303.2 ENSP00000351591.4 Q9NZ94-1
NLGN3ENST00000685718.1 linkn.*1301A>G non_coding_transcript_exon_variant Exon 8 of 8 ENSP00000510514.1 A0A8I5QJU7
NLGN3ENST00000685718.1 linkn.*1301A>G 3_prime_UTR_variant Exon 8 of 8 ENSP00000510514.1 A0A8I5QJU7

Frequencies

GnomAD3 genomes
AF:
0.00201
AC:
225
AN:
111982
Hom.:
0
Cov.:
22
AF XY:
0.00164
AC XY:
56
AN XY:
34134
show subpopulations
Gnomad AFR
AF:
0.000682
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000563
Gnomad ASJ
AF:
0.00227
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00111
Gnomad FIN
AF:
0.000490
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00347
Gnomad OTH
AF:
0.00132
GnomAD3 exomes
AF:
0.00226
AC:
413
AN:
182497
Hom.:
2
AF XY:
0.00222
AC XY:
149
AN XY:
67089
show subpopulations
Gnomad AFR exome
AF:
0.000306
Gnomad AMR exome
AF:
0.000695
Gnomad ASJ exome
AF:
0.00121
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000947
Gnomad FIN exome
AF:
0.000314
Gnomad NFE exome
AF:
0.00427
Gnomad OTH exome
AF:
0.00244
GnomAD4 exome
AF:
0.00401
AC:
4408
AN:
1098145
Hom.:
10
Cov.:
32
AF XY:
0.00379
AC XY:
1376
AN XY:
363503
show subpopulations
Gnomad4 AFR exome
AF:
0.000492
Gnomad4 AMR exome
AF:
0.000909
Gnomad4 ASJ exome
AF:
0.00119
Gnomad4 EAS exome
AF:
0.0000331
Gnomad4 SAS exome
AF:
0.00111
Gnomad4 FIN exome
AF:
0.000568
Gnomad4 NFE exome
AF:
0.00483
Gnomad4 OTH exome
AF:
0.00382
GnomAD4 genome
AF:
0.00201
AC:
225
AN:
112036
Hom.:
0
Cov.:
22
AF XY:
0.00164
AC XY:
56
AN XY:
34198
show subpopulations
Gnomad4 AFR
AF:
0.000681
Gnomad4 AMR
AF:
0.000563
Gnomad4 ASJ
AF:
0.00227
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00111
Gnomad4 FIN
AF:
0.000490
Gnomad4 NFE
AF:
0.00347
Gnomad4 OTH
AF:
0.00131
Alfa
AF:
0.00388
Hom.:
162
Bravo
AF:
0.00243
TwinsUK
AF:
0.00539
AC:
20
ALSPAC
AF:
0.00450
AC:
13
ESP6500AA
AF:
0.00104
AC:
4
ESP6500EA
AF:
0.00401
AC:
27
ExAC
AF:
0.00227
AC:
276

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Nov 01, 2016
CeGaT Center for Human Genetics Tuebingen
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Aug 01, 2018
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

not specified Benign:3
Mar 03, 2017
Genetic Services Laboratory, University of Chicago
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Apr 04, 2014
Eurofins Ntd Llc (ga)
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Inborn genetic diseases Benign:1
Aug 24, 2016
Ambry Genetics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.060
BayesDel_addAF
Benign
-0.54
T
BayesDel_noAF
Benign
-0.54
CADD
Benign
21
DANN
Benign
0.92
DEOGEN2
Benign
0.11
.;.;T
FATHMM_MKL
Uncertain
0.79
D
LIST_S2
Benign
0.72
T;T;T
M_CAP
Benign
0.012
T
MetaRNN
Benign
0.0056
T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.2
.;.;L
PrimateAI
Benign
0.44
T
PROVEAN
Benign
-0.67
N;N;N
REVEL
Benign
0.13
Sift
Benign
0.51
T;T;T
Sift4G
Benign
0.69
T;T;T
Polyphen
0.0
.;B;B
Vest4
0.064
MVP
0.69
MPC
0.26
ClinPred
0.0056
T
GERP RS
4.8
Varity_R
0.20
gMVP
0.68

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs144914894; hg19: chrX-70389354; COSMIC: COSV105267532; COSMIC: COSV105267532; API